CVS Health (NYSE:CVS) Rating Reiterated by SVB Leerink

CVS Health (NYSE:CVS - Get Free Report)'s stock had its "market perform" rating reissued by analysts at SVB Leerink in a research report issued on Wednesday, Marketbeat Ratings reports. They presently have a $60.00 price objective on the pharmacy operator's stock, down from their prior price objective of $87.00. SVB Leerink's target price suggests a potential upside of 6.53% from the company's current price.

CVS has been the topic of several other research reports. Leerink Partnrs reaffirmed an "outperform" rating on shares of CVS Health in a research note on Monday, February 26th. Wells Fargo & Company decreased their price objective on CVS Health from $83.00 to $76.00 and set an "equal weight" rating on the stock in a research note on Monday, April 8th. Barclays initiated coverage on CVS Health in a research note on Wednesday, March 6th. They issued an "equal weight" rating and a $78.00 price objective on the stock. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $87.00 price objective on shares of CVS Health in a research note on Wednesday, April 10th. Finally, Royal Bank of Canada decreased their price objective on CVS Health from $86.00 to $84.00 and set an "outperform" rating on the stock in a research note on Thursday, February 8th. Six research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $86.28.

CVS Health Stock Performance

CVS stock traded down $11.39 during trading on Wednesday, reaching $56.32. The stock had a trading volume of 65,673,895 shares, compared to its average volume of 11,294,945. CVS Health has a 52 week low of $54.00 and a 52 week high of $83.25. The stock's 50 day moving average is $73.63 and its two-hundred day moving average is $73.50. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The firm has a market cap of $70.99 billion, a PE ratio of 8.72, a PEG ratio of 0.89 and a beta of 0.52.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company had revenue of $93.81 billion for the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter in the prior year, the company earned $1.99 earnings per share. CVS Health's revenue was up 11.9% on a year-over-year basis. As a group, equities analysts anticipate that CVS Health will post 8.31 earnings per share for the current year.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.24% of the company's stock.

Hedge Funds Weigh In On CVS Health

A number of large investors have recently bought and sold shares of CVS. Atticus Wealth Management LLC boosted its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator's stock valued at $29,000 after acquiring an additional 219 shares during the period. USA Financial Formulas boosted its holdings in CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator's stock valued at $30,000 after acquiring an additional 321 shares during the period. Cornerstone Planning Group LLC raised its position in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 243 shares in the last quarter. Ables Iannone Moore & Associates Inc. bought a new stake in CVS Health during the 4th quarter valued at $32,000. Finally, Creekmur Asset Management LLC bought a new stake in CVS Health during the 4th quarter valued at $34,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.